Jason T. Bariteau

Jason T. Bariteau

Auto-generated profile, based on publicly available information

Jason T. Bariteau

Emory University School of Medicine, Department of Orthopaedic Surgery, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2022 in Foot & Ankle Orthopaedics
Verified
Journal Article
Open access
AAAhmed K. Attia
Ahmed K. Attia
KKKarim Mahmoud Khamis
Karim Mahmoud Khamis
PDPieter Dhooghe
Pieter Dhooghe
JBJason T. Bariteau
Jason T. Bariteau
SLSameh A. Labib
Sameh A. Labib
MMMark S. Myerson
Mark S. Myerson
Category: Ankle; Sports; Trauma Introduction/Purpose: Traditionally, open surgical repair has provided improved functional outcomes, reduced re-rupture rates, and quicker recovery and return to activities at the expense of increased wound complications of infection and skin necrosis compared to nonoperative management. Ma and Griffith in 1977 introduced the percutaneous approach, and over the following decades, multiple improved techniques, and modifications thereof, have been described with comparable outcomes to the open repair. The current study aims to provide updated level I evidence comparing the open and minimally invasive (MIS) through a comprehensive search of literature published in English, Spanish, Portuguese, and German while avoiding limitations of previous studies such as heterogeneous study designs and a small number of included studies. Methods: Following the PRISMA guidelines, two independent team members searched several databases to identify randomized controlled trials (RCTs) comparing open and MIS Achilles tendon repairs. The primary outcomes were (1) Sural nerve injury, (2) Skin complications, (3) Infection (deep/superficial), whereas the secondary outcomes were (1) AOFAS/ATRS score, (2) surgical time, (3) re-rupture (4) adhesions (5) ankle range of motion. Population: Achilles tendon rupture Intervention: MIS repair Control: Open repair Outcomes: Primary: (1) Sural nerve injury, (2) Skin complications, (3) Infection (deep/superficial) Secondary: (1) AOFAS/ATRS score, (2) surgical time, (3) re-rupture, (4) adhesions, (5) ankle range of motion (6) other complications. Results: Ten RCTs qualified for the meta-analysis with a total of 522 patients. 260(49.8%) patients had open repair while 262(50.2%) had MIS repair. The mean total complication rate was 15.5% (0-36.4%) in open repair vs. 10.4% (0-45.5%) in MIS repair, with non-significant statistical difference (RR= 1.50,CI=0.87-2.57,p= 0.14;I2=40%). The mean re-rupture rate was 2.5% (0-6.8%) in open repair vs. 1.53% (0-4.6%) with MIS repair, with non-significant statistical difference (RR=1.56,CI=0.42-5.70,p= 0.50;I2=0%). No cases of sural nerve injury were reported in the open repair group. The mean sural nerve injury was 3.4%(0-7.3%) in the MIS group, that was statistically significant (RR= 0.16,CI=0.03-0.46,p=0.02;I2=0%). The mean deep infection rate in the open group was 1.4% (0-5%) while no deep infection was reported in MIS, with no statistically significant difference (RR= 3.24,CI=0.48-20.54,p= 0.23;I2=0%). The mean superficial infection rate was 6.04% (0-18.2%) and 0.40% (0-4.5%) for open and MIS repairs, respectively, with statistically significant difference (RR= 5.70,CI=1.80-18.02,p< 0.001;I2=0%). Conclusion: Open Achilles tendon repair is associated with longer surgical time, higher risk of superficial infection, and ankle stiffness, while MIS repair is associated with a greater risk of temporary sural nerve palsy. Re-rupture rate and functional outcomes are mostly equivalent. We found MIS to be a safe and reliable technique. However, high-quality standardized RCTs are still needed before recommending MIS as the gold standard for the management of Achilles tendon rupture.

18 April 2025 in Foot & Ankle International
Verified
Journal Article
Closed access
JBJason T. Bariteau
Jason T. Bariteau
CDConstantine A. Demetracopoulos
Constantine A. Demetracopoulos
AAAhmed Khalil Attia
Ahmed Khalil Attia
Nacime Salomão Barbachan MansurNacime Salomão Barbachan Mansur
Nacime Salomão Barbachan Mansur
DSDaniel J. Scott
Daniel J. Scott
Amy LenzAmy Lenz
Amy Lenz

1 October 2023 in Foot & Ankle Orthopaedics
Verified
Journal Article
Open access
MCMyra Chao
Myra Chao
WMWesley Manz
Wesley Manz
JNJoseph Novack
Joseph Novack
JFJuliet Fink
Juliet Fink
RKRishin J. Kadakia
Rishin J. Kadakia
JBJason T. Bariteau
Jason T. Bariteau
Category: Ankle; Other Introduction/Purpose: The rising prevalence of obesity may drastically affect arthroplasty eligibility as Body Mass Index (BMI) remains a commonly used screening criterion. As obesity disproportionately affects Black adults and women, using such a criterion without scientific merit may lead to inequitable access to care. Particularly in total ankle arthroplasty – where weight has been previously attributed to aseptic implant failure – close examination of screening criteria is imperative. The purpose of this study was to evaluate for disparities in patient eligibility for total ankle arthroplasty (TAA) based on race, ethnicity, gender, and age by applying commonly used BMI cutoffs to the American College of Surgeons National Surgical Quality Improvement Program (ACS- NSQIP) database. Methods: Patients in the ACS-NSQIP database who underwent TAA from 2011- 2020 were retrospectively reviewed. BMI cutoffs of < 35, < 40, < 45, and < 50 were applied to the cohort to model the rate of surgical eligibility for TAA. Patients were deemed eligible for surgery if their BMI was less than each modeled BMI cutoff and ineligible if their BMI was equal to or greater than the cutoff. The relative eligibility rate, which was defined as the rate of eligibility minus the rate of ineligibility, was examined for each BMI cutoff. The cohorts were then stratified by race, ethnicity, gender, and age. Independent T-tests, Chi-squared tests, and Fisher’s exact tests were performed to compare differences at an α = 0.05. Results: 65.1% of all TAA patients were included after applying the exclusion criteria. Black patients had disproportionately lower rates of eligibility at the most stringent BMI cutoff of < 35kg/m² (p=0.004). Hispanic patients had generally lower rates of eligibility across all BMI cutoffs. In contrast, Asian American and Pacific Islander patients had higher rates of eligibility at the BMI cutoffs of < 35kg/m² (p=0.033) and < 40kg/m² (p=0.039), and White non-Hispanic patients had higher rates of eligibility across all BMI cutoffs. Females had lower eligibility rates across all BMI cutoffs. Ineligible patients were also younger compared to eligible patients across all BMI cutoffs. Conclusion: Stringent BMI cutoffs may disproportionately disqualify Black, female, and younger patients from receiving total ankle arthroplasty. The data suggests that current eligibility criteria may exacerbate disparity in access to TAA for historically vulnerable populations. While eligibility criteria exist to protect patients from interventions that put them at unacceptable risk, these criteria are not uniformly distributed across populations. Given these data and the rising obesity epidemic, additional highly powered studies are needed to determine the safety of TAA in patients with BMI 35-40 to ensure at-risk populations are not disproportionately excluded from mobility-improving surgery.

2 June 2026 in Foot & Ankle International
Verified
Journal Article
Closed access
JBJason T. Bariteau
Jason T. Bariteau
SOShervin Oskouei
Shervin Oskouei

16 October 2026 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
TDTyler D. DeSena
Tyler D. DeSena
PFPaul H. Fine-Lease
Paul H. Fine-Lease
JHJason L Hornick
Jason L Hornick
EPEmily B. Parker
Emily B. Parker
GKGiovanna Kalin
Giovanna Kalin
CCChristopher P. Chiodo
Christopher P. Chiodo
Background: Gout can affect tendons in addition to joints and may clinically resemble infection. The resulting diagnostic uncertainty may lead to surgical intervention or antibiotic treatment, even in patients whose symptoms might be managed medically if gout is recognized earlier. Questions/purposes: (1) Does late-onset gouty Achilles tendinopathy after prior Achilles tendon repair clinically resemble infection? (2) What diagnostic findings, including crystal analysis of aspirate or surgically obtained material when available, helped establish or support gout rather than infection? (3) What were the outcomes after gout was confirmed or suspected? Methods: This is a report of 4 patients with a similar presentation. Between April 2021 and June 2024, three surgeons at three academic medical centers identified 4 adult males, aged 42 to 55 years, who developed acute atraumatic Achilles-region pain, swelling, erythema, drainage, fluctuance, or induration 2 to 18 years after open Achilles tendon repair. These presentations raised concern that gout at or near a prior Achilles tendon repair site may mimic infection and lead to unnecessary interventions when gout is not considered early. We do not have an underlying denominator of patients treated for Achilles tendon repair by these surgeons during this period, but we speculate that it is on the order of several hundred. Minimum follow-up was 6 months after the treatment selected for the index Achilles inflammatory presentation. No patients who met these criteria were excluded, and no patients were lost to follow-up before the minimum follow-up interval. To determine whether this presentation clinically resembled infection, we reviewed presenting symptoms and physical examination findings, including pain, swelling, erythema, drainage, fluctuance, induration, fever, constitutional symptoms, and the treating surgeon’s initial diagnostic concern. To answer our second question regarding diagnostic findings that established or supported gout rather than infection, we reviewed laboratory studies, imaging, aspiration findings, Gram stain, bacterial cultures, surgical findings, and pathologic evaluation for monosodium urate crystals. To answer our third question regarding outcomes, we reviewed whether patients underwent aspiration, surgical irrigation and debridement, antibiotics, immobilization, antiinflammatory or urate-lowering therapy, rheumatology or infectious disease referral, symptom resolution, recurrence, and complications. Three patients underwent aspiration and/or surgical irrigation and debridement for presumed infection. One patient was treated nonsurgically for suspected gout. Results: In 3 of 4 patients, late-onset gouty Achilles tendinopathy after prior Achilles tendon repair clinically resembled infection; it raised concern for an acute inflammatory or infectious process in all 4 patients. Among the 3 patients treated surgically, chalky tophaceous material was identified adjacent to the Achilles tendon, bacterial cultures were negative, and histological analysis confirmed monosodium urate crystals. The fourth patient had suspected gout based on hyperuricemia, Achilles-region symptoms, and improvement with nonsurgical treatment, although gout was not pathologically confirmed. All patients reported symptom resolution by latest follow-up (6 to 16 months). Conclusion: Acute gouty tendinopathy can present years after Achilles tendon repair and can closely mimic postoperative infection, even when serum uric acid is normal. In patients without systemic signs of sepsis, earlier consideration of gout and routine crystal analysis when aspirate or surgically obtained material is available may help avoid unnecessary surgical debridement or prolonged empiric antibiotics when infection is not otherwise supported. Level Of Evidence: Level IV, therapeutic study.

31 January 2026 in Foot & Ankle Orthopaedics
Verified
Journal Article
Open access
CDCaroline M. Dingler
Caroline M. Dingler
CHCharles C. Hower
Charles C. Hower
KKKevin T. Kane
Kevin T. Kane
AEAlicia G. Edwards
Alicia G. Edwards
RKRishin J. Kadakia
Rishin J. Kadakia
JBJason T. Bariteau
Jason T. Bariteau
Background: First metatarsophalangeal (MTP) joint fusion is a common surgical procedure to treat hallux rigidus and malalignment at the MTP joint. Nonunion after first MTP arthrodesis can cause continued pain and limitation in function. The present study aims to provide a single-site analysis of nonunion risk factors after first MTP fusion. We hypothesized that diabetes, smoking, and a body mass index (BMI) ≥30 are associated with increased risk of nonunion. Methods: This is a retrospective cohort study. All patients who underwent first MTP fusion performed by 3 orthopaedic foot and ankle surgeons between September 20, 2013, and September 20, 2023, were included. Patient demographics, comorbidities, intraoperative medications, and postoperative complications were collected. Relationships to nonunion were evaluated using the multivariable logistic regression (a < 0.05) and both odds ratio (OR) and adjusted odds ratio (aOR) were calculated. Results: A total of 417 patients (450 feet) were included. Average BMI was 27.94 ± 6.79. There were 25 nonunions, which did not statistically differ in sex or age. Per-patient models identified idiopathic peripheral neuropathy and bilateral surgeries as independent predictors, with BMI ≥30 showing a trend toward significance. Diagnosis of peripheral neuropathy was subdivided into diabetic and idiopathic peripheral neuropathy, with increased nonunion rates in the idiopathic group. Osteoporosis, bisphosphonate use, and smoking history showed no statistical difference in nonunion rates. BMI and diabetes showed statistical differences with univariate logistic regression but were deemed insignificant on multivariate analysis. Conclusion: In this single-institution cohort, idiopathic peripheral neuropathy and bilateral MTP fusions were associated with higher odds of nonunion; findings for BMI ≥30 and diabetes should be interpreted prudently, given the limited events and wide CIs. Level of Evidence: Level III, retrospective cohort study.